Titel

Merkliste
1 Ergebnisse

MERAIODE: A Phase II Redifferentiation Trial with Trametini..:

Leboulleux, Sophie ; Do Cao, Christine ; Zerdoud, Slimane...
info:eu-repo/semantics/altIdentifier/doi/10.1158/1078-0432.CCR-23-0046. , 2023

Link: https://inserm.hal.science/inserm-04552345

RT Journal
T1 <Title>MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131 I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated thyroid Cancer</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivaixmarseil:oai:HAL:inserm-04552345v1&Exemplar=1&LAN=DE
				
A1 Leboulleux, Sophie
A1 Do Cao, Christine
A1 Zerdoud, Slimane
A1 Attard, Marie
A1 Bournaud, Claire
A1 Lacroix, Ludovic
A1 Benisvy, Danielle
A1 Taïeb, David
A1 Bardet, Stéphane
A1 Terroir-Cassou-Mounat, Marie
A1 Anizan, Nadège
A1 Bouvier-Morel, Emilie
A1 Lamartina, Livia
A1 Lion, Georges
A1 Betrian, Sarah
A1 Sajous, Christophe
A1 Schiazza, Aurélie
A1 Garcia, Marie-Eve
A1 Ciappuccini, Renaud
A1 Schlumberger, Martin
A1 Al Ghuzlan, Abir
A1 Godbert, Yann
A1 Borget, Isabelle
PB HAL CCSD; American Association for Cancer Research
YR 2023
K1 refractory thyroid cancer
K1 RAS mutation
K1 redifferentiation
K1 trametinib
K1 anti-MEK
K1 [SDV.CAN]Life Sciences [q-bio]/Cancer
K1 [SHS.STAT]Humanities and Social Sciences/Methods and statistics
K1 [STAT]Statistics [stat]
K1 [STAT.OT]Statistics [stat]/Other Statistics [stat.ML]
K1 [STAT.ME]Statistics [stat]/Methodology [stat.ME]
JF info:eu-repo/semantics/altIdentifier/doi/10.1158/1078-0432.CCR-23-0046
LK http://dx.doi.org/https://inserm.hal.science/inserm-04552345
DO https://inserm.hal.science/inserm-04552345
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)